EHAB Stock Analysis: Buy, Sell, or Hold?

EHAB - Enhabit, Inc.

SERVICES-HOME HEALTH CARE SERVICES
$13.80
0.01 (0.07%) ▲
5d: +0.22%
30d: +0.66%
90d: +22.99%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 13, 2026 0d

Get Alerted When EHAB Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: EHAB shows positive signals but monitor for confirmation. Market pricing in 2.1% annual growth which appears achievable. Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$11.81
Based on -1.8% avg growth
INTRINSIC VALUE TODAY
$7.33
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: EHAB is currently trading at $13.80, which is considered fair relative to its 30-day fair value range of $13.71 to $13.91. The stock's valuation (Forward PE: 20.9) is in line with its historical norms (19.6). At these levels, the market is pricing in 2.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, EHAB is in a strong uptrend. The price is currently testing key support at $13.74. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $13.71 - $13.91
Company Quality Score 53/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 68.6%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($13.80)
  • NEUTRAL: Market pricing in 2.1% annual earnings growth - fairly valued

Trading Range Analysis

30-Day Trading Range $13.71 - $13.91
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $13.74
Resistance Level $13.81
Current Trend Strong Uptrend
Technical data as of May 14, 2026

Fundamental Context

Forward P/E (Next Year Est.) 20.87
Wall Street Target $13.80
Revenue Growth (YoY) 1.9%
Earnings Growth (YoY) 2.9%
Profit Margin -0.3%
Valuation Premium vs History +2.1% premium
PE vs Historical 20.9 vs 19.6 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +2.1% (market-implied from PE analysis)
1-Year Target $14.09 (+2%)
2-Year Target $14.39 (+4%)
3-Year Target $14.69 (+6%)
3-Yr Target (if PE normalizes) (PE: 21→20) PE COMPRESSION $13.79 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.0, Growth: -7.5%) $11.52 (+-17%)
Base: (SPY PE: 20.9, Growth: -7.5%) $10.91 (-21%)
Bear: (PE: 17.7, Growth: -7.5%) $9.27 (-33%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 15, 2026 9:18 AM ET
Data refreshes hourly during market hours. Next update: 10:18 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Collin Mcquiddy SELL 1403 shares 2026-03-11
Julie Diane Jolley SELL 2793 shares 2026-03-09

Unlock Insider Activity

See real-time buying/selling by company executives for EHAB.

Create Free Account

Already have an account? Log In

Top Rated Medical Care Facilities Stocks

Top-rated stocks in Medical Care Facilities by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
HCA
HCA Holdings Inc
BUY
25 analysts
$513 66 BUY
THC
Tenet Healthcare Corpora…
STRONG BUY
22 analysts
$246 59 HOLD
EHC
Encompass Health Corp
STRONG BUY
12 analysts
$141 62 BUY
CMPS
Compass Pathways Plc
STRONG BUY
11 analysts
$21 63 BUY
CON
Concentra Group Holdings…
STRONG BUY
8 analysts
$30 62 BUY

More Analysis for EHAB

EHAB Technical Chart EHAB Price Prediction EHAB Earnings Date EHAB Investment Advisor EHAB Fair Price Analyzer EHAB Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals